
Novel highly селективный negative allosteric modulator (NAM) of thyrotropin рецептор (TSHR), связывание at the ectodomain/TMD interface, between the converging helix, ECL1 and the IA, noncompetitively inhibiting PAM-C2-activation
Novel highly selective negative allosteric modulator (NAM) of thyrotropin receptor (TSHR), binding at the ectodomain/TMD interface, between the converging helix, ECL1 and the IA, noncompetitively inhibiting PAM-C2-activation
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.